Edition:
India

Onconova Therapeutics Inc (ONTX.OQ)

ONTX.OQ on NASDAQ Stock Exchange Capital Market

1.09USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$1.09
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
55,324
52-wk High
$3.88
52-wk Low
$0.95

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.34 December 23 Feb 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 3 3 4 4
(3) HOLD 1 1 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.25 2.25 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 1 0.00 0.00 0.00 --
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 3 1.84 5.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-18 1 -0.34 -0.34 -0.34 -0.44
Quarter Ending Jun-18 1 -0.36 -0.36 -0.36 -0.46
Year Ending Dec-18 3 -1.79 -1.28 -2.06 -1.93

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.15 0.11 0.04 27.49
Quarter Ending Jun-17 0.22 0.32 0.11 50.70
Quarter Ending Mar-17 0.16 0.21 0.05 31.25
Quarter Ending Dec-16 1.00 0.17 0.83 82.70
Quarter Ending Sep-16 1.00 1.65 0.65 65.10

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 0.00 0.00 0.00 -- --
Quarter Ending Jun-18 0.00 0.00 0.00 -- --
Year Ending Dec-18 1.84 1.84 1.84 3.09 0.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 0 0
Quarter Ending Jun-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings